The University of California, Irvine School of Medicine (UC Irvine School of Medicine or UCI School of Medicine) is an LCME accredited medical school, co-located in Orange County's cities of Irvine on the University of California, Irvine campus and Orange at the UC Irvine Medical Center. Of the medical schools evaluated for its 2013 edition (released March 13, 2012), U.S News & World Report ranked the school 43rd in Research and 61st in Primary Care. The school was founded in 1896 by A.C. Moore and is the oldest continually operating medical school in the greater Los Angeles area.The school is affiliated with UC Irvine Medical Center and the Children's Hospital of Orange County.
Purpose Employment provides psychological and financial benefits. In this secondary analysis of the Eastern Cooperative Oncology Group- American College of Radiology Imaging Network (ECOG-ACRIN) EAQ162CD study results, we assessed longitudinal changes in employment and work productivity among individuals with stage I–III colorectal cancer and their association with financial hardship.Methods Adults with newly diagnosed stage I–III colorectal cancer treated with curative intent (2018–2020) were surveyed at enrollment, 3, 6, and 12 months. Employment, productivity, and work impairment were measured. Financial hardship was measured using the Comprehensive Score for Financial Toxicity (COST). Longitudinal associations were analyzed using multivariable models.Results Among 280 participants (mean age 55.5; 56.1% [157/280] male) 16.4% (46/280) reported decreased employment at enrollment vs. 4.2% (4/96) at 12 months; employment increases rose from 1.4% (4/280) at enrollment vs. 9.4% (9/96) at 12 months. Higher COST scores (lower hardship) were associated with lower odds of employment change. Among 202 participants employed at enrollment, median work missed declined from 21.9% at enrollment to 0% at follow-up. Physical work ability improved, while mental work ability transiently declined. Employment disruption occurred early, but improved over time.Conclusions These findings highlight the importance of early identification and support for individuals experiencing employment disruption and financial hardship during cancer treatment.
Despite efforts over the last decade by clinical investigators and organizations to enhance diversity in clinical trials, significant underrepresentation of Asian, Asian Pacific Islander, and Hispanic patients remains an issue. Our editorial highlights key barriers to achieving equity in clinical trial enrollment among patients with non-small cell lung cancer (NSCLC) along with strategies to improve diversity to ensure more generalized clinical outcomes. Adult Asian, Asian Pacific Islander, and Hispanic patients with non-small cell lung cancer (NSCLC) are enrolled at much lower rates compared with their white counterparts. Given the high mortality of NSCLC and mutations that drive cancer growth that are different among ethnic/racial groups, it is crucial to improve equity in clinical trial enrollment.
Recombinant adeno-associated virus (AAV) vectors are predominantly nonintegrating, but rare genomic integration events have been associated with oncogenesis in neonatal murine models. Here we report a case of a neuroepithelial tumor that developed in a 5-year-old boy with severe mucopolysaccharidosis type I (MPSI, Hurler subtype) 4 years after intracisternal magna administration of AAV serotype 9 gene therapy. The patient underwent successful resection of the primary tumor. Postoperatively, he has continued to have advanced cognitive function for his age, a finding that indicates mitigation of MPSI. Molecular analysis of the tumor showed clonal integration of rearranged AAV vector elements into the gene PLAG1 and expression of a chimeric AAV-PLAG1 transcript.
Purpose Brain–computer interfaces (BCIs) offer a pathway to restore ambulation in indi-viduals with spinal cord injury (SCI). However, existing BCI systems for gait are unidirectional and lack sensory feedback. This study aimed to demonstrate that a bidirectional brain–computer interface (BDBCI) can simultaneously enable real-time brain-controlled walking and artificial leg sensation via electrical stimulation of the sensory cortex. Methods Epilepsy patients undergoing bilateral interhemispheric subdural electrocorticog-raphy (ECoG) implantation were recruited for this proof-of-concept study. Motor mapping identified electrodes in the leg motor cortex for decoding stepping intent, while sensory stimu-lation mapping determined stimulation sites in the somatosensory cortex to elicit artificial leg percepts. A custom embedded BDBCI decoded motor intent in real time to actuate a robotic gait exoskeleton (RGE) from ECoG signals and delivered leg swing sensory feedback via direct cortical stimulation. Performance was assessed through correlations between cued and decoded states, sensory reliability tasks, and control experiments. Results One subject was recruited and achieved a high decoding performance (ρ = 0.92 ± 0.04, lag of 3.5 ± 0.5 s) across 10 runs of operating the BDBCI-controlled RGE. Bilateral leg percepts were validated through a blind step-counting task (92.8% accuracy, p < 10−6). Control experiments verified that decoding was not affected by stimulation artifacts. No adverse events were reported. Discussion This study establishes the feasibility of an embedded system BDBCI for restor-ing both motor control and artificial sensation of walking. Leveraging interhemispheric leg sen-sorimotor cortices is safe and yields superior decoding compared to prior lateral brain convexity approaches. These findings provide a foundation for translating BDBCI technology into fully implantable systems for SCI patients with paraplegia.